Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial

医学 帕雷昔布 羟考酮 随机对照试验 优势比 置信区间 塞来昔布 止痛药 肝细胞癌 不利影响 麻醉 外科 内科学 类阿片 受体
作者
Ning Lyu,Yanan Kong,Xiaoxian Li,Na Guo,Jinfa Lai,Jibin Li,Ming Zhao
出处
期刊:Journal of The American College of Radiology [Elsevier BV]
卷期号:19 (1): 61-70 被引量:8
标识
DOI:10.1016/j.jacr.2021.09.029
摘要

Pain is one of the most common side effects of transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma. The goal of this study is to compare the analgesic effect among celecoxib, parecoxib, and oxycodone in patients undergoing TACE.This prospective study was a randomized, paralleled trial in which 213 patients were enrolled. Patients were assigned at the ratio of 1:1:1 to receive celecoxib, parecoxib, or controlled-release oxycodone 1 hour before TACE (T0) and once every 12 hours for 2 days after TACE. Pain scores, pain intensity, and adverse events in each time interval were evaluated and compared among the 3 groups.The mean pain score 12 hours after T0 in the parecoxib group (2.8) was lower than that in the celecoxib (4.4; P = .001) and oxycodone groups (4.2; P = .005). The number of patients suffering severe pain was 10 (14.7%) in the parecoxib, 25 (36.8%) in the celecoxib, and 23 (32.9%) in the oxycodone groups (P = .009). Twelve hours after T0, the incidence of grade 3 vomiting in the parecoxib group (2.9%) was significantly lower than that in the oxycodone group (17.1%; P = .006). In the multivariate analysis, nonparecoxib prophylactic analgesia (odds ratio [OR], 4.620; 95% confidence interval [CI], 1.877-11.370; P = .001) as well as embolization of the gallbladder (OR, 8.666; 95% CI, 2.402-31.262; P = .001) and normal liver parenchyma (OR, 3.278; 95% CI, 1.409-7.627; P = .006) were the independent factors of severe pain intensity 12 hours after T0.Parecoxib is superior to oxycodone and celecoxib for pain control with fewer adverse events. Therefore, we recommend parecoxib as a priority strategy for TACE-related pain control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
alick完成签到,获得积分10
1秒前
刘刘完成签到,获得积分10
2秒前
Tom完成签到,获得积分10
3秒前
Villanellel发布了新的文献求助10
4秒前
程艳完成签到 ,获得积分10
5秒前
MINGHUI完成签到,获得积分10
6秒前
6秒前
子车半烟完成签到,获得积分10
6秒前
8秒前
淳于安筠完成签到,获得积分10
8秒前
雨晴完成签到,获得积分10
11秒前
jbq发布了新的文献求助10
11秒前
joshar完成签到,获得积分10
11秒前
12秒前
量子星尘发布了新的文献求助10
14秒前
blueblue完成签到,获得积分10
16秒前
落后秋烟完成签到,获得积分10
18秒前
大橙子发布了新的文献求助10
19秒前
LMY完成签到 ,获得积分10
19秒前
Betty完成签到 ,获得积分10
19秒前
NexusExplorer应助jbq采纳,获得10
20秒前
渔渔完成签到 ,获得积分10
20秒前
21秒前
Tangyartie完成签到 ,获得积分10
21秒前
skbkbe完成签到 ,获得积分10
22秒前
陈俊雷完成签到 ,获得积分0
23秒前
阿苗完成签到,获得积分10
24秒前
神勇的天问完成签到 ,获得积分10
25秒前
25秒前
advance完成签到,获得积分10
25秒前
李cc发布了新的文献求助10
26秒前
蒋念寒发布了新的文献求助10
27秒前
Sindy完成签到,获得积分10
27秒前
彭于晏应助HH采纳,获得30
29秒前
29秒前
朴实的小萱完成签到 ,获得积分10
30秒前
科研通AI5应助哭泣笑柳采纳,获得10
30秒前
30秒前
温暖的蚂蚁完成签到 ,获得积分10
33秒前
dhn123完成签到,获得积分10
33秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038184
求助须知:如何正确求助?哪些是违规求助? 3575908
关于积分的说明 11373872
捐赠科研通 3305715
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022